Invention Grant
- Patent Title: Imidazopyridazines as modulators of IL-17
-
Application No.: US17242512Application Date: 2021-04-28
-
Publication No.: US11691979B2Publication Date: 2023-07-04
- Inventor: Steven Goldberg , Craig Woods , Timothy B. Rhorer , Connor Martin , Steven P. Meduna , Stefan McCarver , Alexander Valdes , Steven Loskot , Douglas Behenna , Alexander Raymond Rovira , Xiaohua Xue
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee Address: BE Beerse
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
The present application discloses compounds having the following formula:
or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
Public/Granted literature
- US20220402922A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 Public/Granted day:2022-12-22
Information query
